ECOR - electroCore, Inc. Stock Analysis | Stock Taper
Logo

About electroCore, Inc.

https://www.electrocore.com

electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults.

Daniel S. Goldberger

CEO

Daniel S. Goldberger

Compensation Summary
(Year 2024)

Salary $631,071
Bonus $473,250
Stock Awards $486,000
All Other Compensation $28,264
Total Compensation $1,618,585
Industry Medical - Devices
Sector Healthcare
Went public June 22, 2018
Method of going public IPO
Full time employees 73

Split Record

Date Type Ratio
2023-02-15 Reverse 1:15

ETFs Holding This Stock

Summary

Total 12

Showing Top 2 of 12

Ratings Snapshot

Rating : C-

Discounted Cash Flow 3
Return On Equity 1
Return On Assets 1
Debt To Equity 1
Price To Earnings 1
Price To Book 1
Overall Score 1

Most Recent Analyst Grades

Grade Summary

Buy 2

Showing Top 2 of 2

Price Target

Target High $0
Target Low $0
Target Median $0
Target Consensus $0

Institutional Ownership